Identification of novel drug targets for liver cirrhosis and its potential side-effects by human plasma proteome
Abstract Liver cirrhosis, a common liver disease, currently lacks specific targeted therapies. This study investigates the potential therapeutic effects of serum circulating proteins on cirrhosis from a genetic perspective, and identified six associated plasma proteins (SERPINA1, PSG5, NCAN, APOE, A...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-80483-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850163103820414976 |
|---|---|
| author | Qing-Ao Xiao Wen-Jiang Zhao Jing Yu Lei Qin Xiao-Lin Zhang Jin Yu |
| author_facet | Qing-Ao Xiao Wen-Jiang Zhao Jing Yu Lei Qin Xiao-Lin Zhang Jin Yu |
| author_sort | Qing-Ao Xiao |
| collection | DOAJ |
| description | Abstract Liver cirrhosis, a common liver disease, currently lacks specific targeted therapies. This study investigates the potential therapeutic effects of serum circulating proteins on cirrhosis from a genetic perspective, and identified six associated plasma proteins (SERPINA1, PSG5, NCAN, APOE, ADH1B, GM2A). To search for therapeutic drugs associated with circulating proteins, databases such as DrugBank and DGIdb are utilized. Phenome-wide Mendelian Randomization analysis of the six significantly associated proteins revealed that GM2A exhibited no notable side effects as a therapeutic target for cirrhosis, SERPINA1 may offer additional therapeutic benefits for cholelithiasis and emphysema. ADH1B serves as a potential drug target that could simultaneously reduce the risk of alcohol-related disorders and hypertension. Furthermore, PSG5 and APOE might increase the risk of cardiovascular and neurological diseases, and NCAN has the potential to additionally reduce the risk of developing non-alcoholic fatty liver disease NAFLD. In conclusions, this study substantiates, from a genetic perspective, the potential therapeutic target role of six plasma proteins in cirrhosis, while comprehensively evaluating their side effects. |
| format | Article |
| id | doaj-art-952e95045e574a63b0cd16b2ea3d723f |
| institution | OA Journals |
| issn | 2045-2322 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-952e95045e574a63b0cd16b2ea3d723f2025-08-20T02:22:21ZengNature PortfolioScientific Reports2045-23222024-11-0114111110.1038/s41598-024-80483-2Identification of novel drug targets for liver cirrhosis and its potential side-effects by human plasma proteomeQing-Ao Xiao0Wen-Jiang Zhao1Jing Yu2Lei Qin3Xiao-Lin Zhang4Jin Yu5Department of Interventional Radiology, the First College of Clinical Medical Science, China Three Gorges UniversityDepartment of Interventional Radiology, the First College of Clinical Medical Science, China Three Gorges UniversityDepartment of Interventional Radiology, the First College of Clinical Medical Science, China Three Gorges UniversityDepartment of Interventional Radiology, the First College of Clinical Medical Science, China Three Gorges UniversityDepartment of Interventional Radiology, the First College of Clinical Medical Science, China Three Gorges UniversityDepartment of Interventional Radiology, the First College of Clinical Medical Science, China Three Gorges UniversityAbstract Liver cirrhosis, a common liver disease, currently lacks specific targeted therapies. This study investigates the potential therapeutic effects of serum circulating proteins on cirrhosis from a genetic perspective, and identified six associated plasma proteins (SERPINA1, PSG5, NCAN, APOE, ADH1B, GM2A). To search for therapeutic drugs associated with circulating proteins, databases such as DrugBank and DGIdb are utilized. Phenome-wide Mendelian Randomization analysis of the six significantly associated proteins revealed that GM2A exhibited no notable side effects as a therapeutic target for cirrhosis, SERPINA1 may offer additional therapeutic benefits for cholelithiasis and emphysema. ADH1B serves as a potential drug target that could simultaneously reduce the risk of alcohol-related disorders and hypertension. Furthermore, PSG5 and APOE might increase the risk of cardiovascular and neurological diseases, and NCAN has the potential to additionally reduce the risk of developing non-alcoholic fatty liver disease NAFLD. In conclusions, this study substantiates, from a genetic perspective, the potential therapeutic target role of six plasma proteins in cirrhosis, while comprehensively evaluating their side effects.https://doi.org/10.1038/s41598-024-80483-2Durg targetsMendelian randomizationProteome-wide mendelian randomizationCirrhosis |
| spellingShingle | Qing-Ao Xiao Wen-Jiang Zhao Jing Yu Lei Qin Xiao-Lin Zhang Jin Yu Identification of novel drug targets for liver cirrhosis and its potential side-effects by human plasma proteome Scientific Reports Durg targets Mendelian randomization Proteome-wide mendelian randomization Cirrhosis |
| title | Identification of novel drug targets for liver cirrhosis and its potential side-effects by human plasma proteome |
| title_full | Identification of novel drug targets for liver cirrhosis and its potential side-effects by human plasma proteome |
| title_fullStr | Identification of novel drug targets for liver cirrhosis and its potential side-effects by human plasma proteome |
| title_full_unstemmed | Identification of novel drug targets for liver cirrhosis and its potential side-effects by human plasma proteome |
| title_short | Identification of novel drug targets for liver cirrhosis and its potential side-effects by human plasma proteome |
| title_sort | identification of novel drug targets for liver cirrhosis and its potential side effects by human plasma proteome |
| topic | Durg targets Mendelian randomization Proteome-wide mendelian randomization Cirrhosis |
| url | https://doi.org/10.1038/s41598-024-80483-2 |
| work_keys_str_mv | AT qingaoxiao identificationofnoveldrugtargetsforlivercirrhosisanditspotentialsideeffectsbyhumanplasmaproteome AT wenjiangzhao identificationofnoveldrugtargetsforlivercirrhosisanditspotentialsideeffectsbyhumanplasmaproteome AT jingyu identificationofnoveldrugtargetsforlivercirrhosisanditspotentialsideeffectsbyhumanplasmaproteome AT leiqin identificationofnoveldrugtargetsforlivercirrhosisanditspotentialsideeffectsbyhumanplasmaproteome AT xiaolinzhang identificationofnoveldrugtargetsforlivercirrhosisanditspotentialsideeffectsbyhumanplasmaproteome AT jinyu identificationofnoveldrugtargetsforlivercirrhosisanditspotentialsideeffectsbyhumanplasmaproteome |